Article
Development and Validation of a Prognostic Signature Based on Immune Genes in Cervical Cancer
17 Mar 2021
Abstract excerpt
BACKGROUND: Cervical cancer is one of the most common types of gynecological malignancies worldwide. This study aims to develop an immune signature to predict survival in cervical cancer. METHOD: ) database were included in this study. The immune signature was developed based on prognostic genes. The validation dataset was downloaded from the Gene Expression Omnibus (GEO) database. RESULT: The immune signature...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
